|
Dr. Flavell is also Sterling Professor of Immunobiology at Yale School of Medicine. He received his B.Sc. and Ph.D. degrees in biochemistry from the University of Hull, England, and performed postdoctoral work in Amsterdam and Zurich. Before accepting his current position, Dr. Flavell was first Assistant Professor at the University of Amsterdam; then Head of the Laboratory of Gene Structure and Expression at the National Institute for Medical Research, Mill Hill, London; and subsequently President and Chief Scientific Officer of Biogen Research Corporation, Cambridge, Massachusetts. Dr. Flavell is a fellow of the Royal Society and a member of the National Academy of Sciences. He was recently elected to the Institute of Medicine of the National Academies. In 2008, he received the Invitrogen Meritorious Career Award from the American Association of Immunologists and the Hebrew University–Hadassah Medical School's Rabbi Shai Shacknai Memorial Prize in Immunology and Cancer Research.
RESEARCH ABSTRACT SUMMARY:
Richard Flavell uses mouse reverse genetics to study innate and adaptive immunity, T cell tolerance, apoptosis and autoimmunity, and the regulation of T cell differentiation.
View Research Abstract
Photo: Harold Shapiro
|
